BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16135770)

  • 1. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
    Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM
    Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
    Crocker A; España RA; Papadopoulou M; Saper CB; Faraco J; Sakurai T; Honda M; Mignot E; Scammell TE
    Neurology; 2005 Oct; 65(8):1184-8. PubMed ID: 16247044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 4. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
    Thannickal TC; Nienhuis R; Siegel JM
    Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy.
    Honda M; Arai T; Fukazawa M; Honda Y; Tsuchiya K; Salehi A; Akiyama H; Mignot E
    Neurology; 2009 Aug; 73(7):511-7. PubMed ID: 19687452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.
    Gerashchenko D; Kohls MD; Greco M; Waleh NS; Salin-Pascual R; Kilduff TS; Lappi DA; Shiromani PJ
    J Neurosci; 2001 Sep; 21(18):7273-83. PubMed ID: 11549737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of hypocretin attenuates behavioral changes produced by glutamatergic activation of the perifornical-lateral hypothalamic area.
    Kostin A; Siegel JM; Alam MN
    Sleep; 2014 May; 37(5):1011-20. PubMed ID: 24790280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
    Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients.
    Lodi R; Tonon C; Vignatelli L; Iotti S; Montagna P; Barbiroli B; Plazzi G
    Neurology; 2004 Oct; 63(8):1513-5. PubMed ID: 15505179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice.
    Mochizuki T; Arrigoni E; Marcus JN; Clark EL; Yamamoto M; Honer M; Borroni E; Lowell BB; Elmquist JK; Scammell TE
    Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4471-6. PubMed ID: 21368172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.
    Gerashchenko D; Salin-Pascual R; Shiromani PJ
    Brain Res; 2001 Sep; 913(1):106-15. PubMed ID: 11532254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced number of hypocretin neurons in human narcolepsy.
    Thannickal TC; Moore RY; Nienhuis R; Ramanathan L; Gulyani S; Aldrich M; Cornford M; Siegel JM
    Neuron; 2000 Sep; 27(3):469-74. PubMed ID: 11055430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypocretin/orexin cell transplantation on narcoleptic-like sleep behavior in rats.
    Arias-Carrión O; Murillo-Rodríguez E
    PLoS One; 2014; 9(4):e95342. PubMed ID: 24736646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
    Baumann CR; Stocker R; Imhof HG; Trentz O; Hersberger M; Mignot E; Bassetti CL
    Neurology; 2005 Jul; 65(1):147-9. PubMed ID: 16009905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBP3 colocalizes with and regulates hypocretin (orexin).
    Honda M; Eriksson KS; Zhang S; Tanaka S; Lin L; Salehi A; Hesla PE; Maehlen J; Gaus SE; Yanagisawa M; Sakurai T; Taheri S; Tsuchiya K; Honda Y; Mignot E
    PLoS One; 2009; 4(1):e4254. PubMed ID: 19158946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.
    Thannickal TC; Siegel JM; Nienhuis R; Moore RY
    Brain Pathol; 2003 Jul; 13(3):340-51. PubMed ID: 12946023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.